Visit clinicaltrials.gov to learn about more our DDR inhibitor studies conducted in collaboration with external partners.
References
1. Roidos P, et al. Nat Commun. 2020;11(1):4077; 2. Yap TA, et al. Clin Cancer Res. Published online February 26, 2024, doi:10.1158/1078-0432.CCR-23-2409; 3. ClinicalTrials.gov. Accessed March 29, 2024. https://clinicaltrials.gov/ct2/show/NCT04170153; 4. Siu L, et al. Cancer Res. 2024;84 (Supp 7): CT063;
5. ClinicalTrials.gov. Accessed March 29, 2024. https://clinicaltrials.gov/ct2/show/NCT05396833; 6. ClinicalTrials.gov. Accessed March 29, 2024.
https://clinicaltrials.gov/study/NCT05882734; 7. Zimmermann A, et al. Mol Cancer Ther. 2022;21(6):859-870; 8. ClinicalTrials.gov. Accessed March 29, 2024. https://clinicaltrials.gov/ct2/show/NCT04882917.